2-(2-((6-chloroquinolin-4-yl)methyl)-5,7-bis(cyclopropylmethyl)-4,6-dioxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-d]pyrimidin-3-yl)-1-methyl-1H-imidazole-4-carbonitrile

ID: ALA2088116

Chembl Id: CHEMBL2088116

PubChem CID: 70689064

Max Phase: Preclinical

Molecular Formula: C28H25ClN8O2

Molecular Weight: 541.02

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(C#N)nc1-c1c2c(=O)n(CC3CC3)c(=O)n(CC3CC3)c2nn1Cc1ccnc2ccc(Cl)cc12

Standard InChI:  InChI=1S/C28H25ClN8O2/c1-34-15-20(11-30)32-26(34)24-23-25(33-37(24)14-18-8-9-31-22-7-6-19(29)10-21(18)22)35(12-16-2-3-16)28(39)36(27(23)38)13-17-4-5-17/h6-10,15-17H,2-5,12-14H2,1H3

Standard InChI Key:  HDYWIJLOZYIISS-UHFFFAOYSA-N

Associated Targets(non-human)

murI Glutamate racemase (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Helicobacter pylori (3113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 541.02Molecular Weight (Monoisotopic): 540.1789AlogP: 3.70#Rotatable Bonds: 7
Polar Surface Area: 116.32Molecular Species: NEUTRALHBA: 10HBD:
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.71CX LogP: 4.20CX LogD: 4.20
Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.31Np Likeness Score: -1.25

References

1. Basarab GS, Hill P, Eyermann CJ, Gowravaram M, Käck H, Osimoni E..  (2012)  Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty.,  22  (17): [PMID:22877632] [10.1016/j.bmcl.2012.07.004]

Source